Tumour dormancy and clinical implications in breast cancer

The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients develop metastases many years after apparently successful treatment of their primary cancer. Tumour dormancy may explain the long time between initial diagnosis and treatment of cancer, and occurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelao, L, Criscitiello, C, Fumagalli, L, Locatelli, M, Manunta, S, Esposito, A, Minchella, I, Goldhirsch, A, Curigliano, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660156/
https://www.ncbi.nlm.nih.gov/pubmed/23717341
http://dx.doi.org/10.3332/ecancer.2013.320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660156/
https://www.ncbi.nlm.nih.gov/pubmed/23717341
http://dx.doi.org/10.3332/ecancer.2013.320

Ejemplares similares